 |
| |
The
Domestic Market |
|
| |
Sales volume increases rapidly each year
|
|
Leading positions in blood screening tests for infectious diseases
|
| |
|
|
|
|
| |
|
Professional and experienced sales team. |
| |
|
Nation-wide distribution network throughout China: over 50
sales representatives,45 provincial distributors |
|
|
Our marketing efforts extend to the fields of clinical testing,
disease control and prevention, blood screening etc |
| |
| |
International
Sales |
|
| |
| Wantai's international
sales is implemented mainly through our distributors. Despite of the
early doubts about the liabilities of the China made diagnostic and
screening IVD reagents, now Wantai is enjoying extensive growth with
international sales. The quality and functionality of Wantai's third
generation HIV 1+2 ELISA assay, the hepatitis A, B and C series tests
have been recognized in more than 20 countries and in particular,
in Asia-Pacific rim, Latin America, the Middle East and Eastern Europe.
In the coming years, driven by the changes in the Chinese economy
and China's access into WTO, Wantai is ready to establish an international
sales network of branch offices in selected regions worldwide, which
will enable the company to become an integrated part of the fast developing
international market for in vitro diagnostics and vaccines. |
| |
|
|
